NAFDAC Fails to Control Over 70% Fake Drugs in Circulation—Fidson

May 13, 2017
NAFDAC Fails to Control Over 70% Fake Drugs in Circulation—Fidson

NAFDAC Fails to Control Over 70% Fake Drugs in Circulation—Fidson

By Dipo Olowookere

The National Agency for Food, Drug Administration and Control (NAFDAC) has been blamed for failing to curtail the circulation of fake drugs in the country.

Executive Director of Fidson health Care Plc, Mr Bola Adebayo, told The Nation that the gap created by inadequate genuine manufacturers of drugs in the hinterland has led to the over-bearing presence of counterfeit drugs in villages and semi-urban centres in the country, pointing out that real manufacturers are only concentrated in big cities.

On the challenges faced by his members, he said before now manufacturers literarily ran out of raw materials as a result of forex scarcity.

He, however, praised the Central Bank of Nigeria (CBN) for bending backwards recently by giving them concessionary rate to keep their factories running. He said this has prevented what would have resulted in mass closure of factories.

Mr Adebayo confirmed that most drug firms were encouraging the Federal Government’s Backward Integration Policy by insisting that they buy pet bottles and glasses locally.

On the challenges facing the sector, he recalled that they spend over 50 percent of their working capital on electricity generation.

“Electricity is not available and where it is available it is not usable. We provide our water, security, roads, access to market and debts from both State and Federal Governments,” he said.

Source: The Nation

Dipo Olowookere

Dipo Olowookere is a journalist based in Nigeria that has passion for reporting business news stories. At his leisure time, he watches football and supports 3SC of Ibadan.

Mr Olowookere can be reached via [email protected]

Leave a Reply

We’ll Use Agric to Diversify Economy—CBN Insists
Previous Story

We’ll Use Agric to Diversify Economy—CBN Insists

Corruption Trials: The New Tactics of Evading Justice
Next Story

Corruption Trials: The New Tactics of Evading Justice

Latest from Health

Don't Miss